section name header

Pronunciation

dox-i-SYE-kleen

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: tetracyclines

Indications

REMS


Action

  • Inhibits bacterial protein synthesis at the level of the 30S bacterial ribosome.
  • Low-dose products used in the management of periodontitis inhibit collagenase.
Therapeutic effects:
  • Bacteriostatic action against susceptible bacteria.

Spectrum:

Pharmacokinetics

Absorption: Well absorbed from the GI tract.

Distribution: Widely distributed, some CSF and good bone penetration.

Metabolism/Excretion: 20–40% excreted unchanged in urine; some inactivation in intestine and some enterohepatic circulation with excretion in bile and feces.

Half-Life: 14–17 hr ( in severe renal impairment).

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
PO1–2 hr1.5–4 hr12 hr
IVrapidend of infusion12 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

More Common Infections

Inhalational Anthrax (Postexposure)

Cutaneous Anthrax

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Acticlate, Doryx, Doryx MPC, Doxy, Oracea, Targadox, Vibramycin

Canadian Brand Names

Apprilon, Doxycin, Doxytab, Periostat

Pill Image

doxycycline_hyclate-_195-8724.jpg

Code

NDC Code